SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,568,961 | +12.3% | 507,042 | +1.9% | 0.03% | +14.8% |
| Q2 2023 | $95,790,999 | -2.7% | 497,719 | +2.3% | 0.03% | -10.0% |
| Q1 2023 | $98,480,598 | +60.0% | 486,396 | +1.5% | 0.03% | +50.0% |
| Q4 2022 | $61,560,788 | -0.9% | 479,035 | +5.5% | 0.02% | -9.1% |
| Q3 2022 | $62,149,000 | -19.4% | 454,206 | +4.2% | 0.02% | -18.5% |
| Q2 2022 | $77,101,000 | +26.5% | 435,744 | +3.0% | 0.03% | +50.0% |
| Q1 2022 | $60,956,000 | -2.6% | 423,156 | +4.5% | 0.02% | 0.0% |
| Q4 2021 | $62,599,000 | -6.7% | 404,908 | +2.5% | 0.02% | -18.2% |
| Q3 2021 | $67,068,000 | +14.5% | 394,982 | +6.4% | 0.02% | +15.8% |
| Q2 2021 | $58,594,000 | +15.0% | 371,127 | +1.1% | 0.02% | 0.0% |
| Q1 2021 | $50,966,000 | -28.8% | 367,031 | -10.1% | 0.02% | -32.1% |
| Q4 2020 | $71,542,000 | – | 408,482 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |